Sofinnova Ventures »

Oric Pharmaceuticals shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.6M 680k 12.67
2020-06-30 $585k 17k 33.69

More positions owned by Sofinnova Ventures

Natera (NTRA)
iShares TR Russell 2000 Etf Put Option (IWM)
United Therapeutics Corporation Put Option (UTHR)
SPDR Series Trust State Street Spd Put Option (XBI)
Bristol Myers Squibb (BMY)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Vera Therapeutics Cl A (VERA)
AstraZeneca Ord (AZN)
Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Cogent Biosciences (COGT)
iShares TR Ishares Biotech Put Option (IBB)
Celcuity (CELC)
Ultragenyx Pharmaceutical (RARE)
Axsome Therapeutics Put Option (AXSM)
Rapport Therapeutics (RAPP)

View all positions for Sofinnova Ventures

Top funds holding Oric Pharmaceuticals

Nextech Invest
EcoR1 Capital
BlackRock
Viking Global Investors
Pfizer
Vanguard Group
Sr One Capital Management
Alkeon Capital Management
VR Adviser
State Street Corporation
NEA Management Company
Vanguard Capital Management
Column Group
OrbiMed Advisors
FMR

View all funds holding Oric Pharmaceuticals